vimarsana.com

Latest Breaking News On - Hcw biologics inc - Page 7 : vimarsana.com

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Down 54.6% in May

HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 14,900 shares, a drop of 54.6% from the May 15th total of 32,800 shares. Based on an average daily volume of 28,400 shares, the days-to-cover ratio is […]

Biologics-inc
Geode-capital-management
Hightower-advisors
Renaissance-technologies
Blackrock-inc
Nasdaq
Biologics-company-profile-get-rating
Maxim-group
Hcw-biologics-inc
Get-rating
Tower-advisors

Insider Buying: HCW Biologics Inc. (NASDAQ:HCWB) Director Buys 4,800 Shares of Stock

HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) Director Rick S. Greene bought 4,800 shares of the stock in a transaction that occurred on Thursday, June 2nd. The shares were purchased at an average price of $2.09 per share, for a total transaction of $10,032.00. Following the purchase, the director now owns 8,411 shares in the […]

Ricks-greene
Biologics-inc
Geode-capital-management
Securities-exchange-commission
Hightower-advisors
Blackrock-inc
Nasdaq
Biologics-company-profile-get-rating
Maxim-group
Millennium-management
Hcw-biologics-inc

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update

HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 30,100 shares, a decrease of 32.5% from the April 15th total of 44,600 shares. Based on an average daily volume of 32,700 shares, the days-to-cover ratio is presently 0.9 days. […]

Biologics-inc
Geode-capital-management
Goldman-sachs-group-inc
Hightower-advisors
Renaissance-technologies
Nasdaq
Maxim-group
Hcw-biologics-inc
Get-rating
Tower-advisors
Sachs-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.